GENE ONLINE|News &
Opinion
Blog

Hemophilia
Trials & Approvals Hemophilia B
Pfizer’s Hemophilia B Gene Therapy Meets Phase 3 Endpoints
2022-12-30
Hemophilia
New Approaches to Effectively Manage Hemophilia in Pregnant Women
2022-04-15
Interviews Hemophilia B
The Transformative Potential of Gene Therapies for Hemophilia
2021-04-08
Trials & Approvals
Roche Announces Analysis of Hemlibra’s Phase III HAVEN 2 Study at ASH meeting
2018-12-21
Trials & Approvals Hemophilia A
Emicizumab promises weekly/biweekly prophylaxis in hemophilia-A patients
2018-09-04
LATEST
Health Insurers Adopt Wearable Data Tracking Models Similar to Automotive Telematics
2026-08-14
Biogen’s Alzheimer’s Tau Drug Splits Experts: Can Diranersen Challenge Leqembi?
2026-08-14
Definium’s Psychedelic Anxiety Drug DT120 Moves Closer to the Mainstream With a Phase 3 Win
2026-08-14
JAMA Network Open Study Links Agent Orange and Burn Pit Exposure to Veteran Health Outcomes
2026-08-14
La Mojana Earthworks Reveal Long-Term Sustainable Water Management by Pre-Hispanic Societies
2026-08-13
Grant Evaluators Divided Over Prioritizing Past Performance Versus Future Potential
2026-08-13
UC Riverside Study Finds High-Intensity Running Does Not Reduce Lifespan in Mice
2026-08-13
READ MORE
EVENT
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
2026-10-23
ESMO Congress 2026 (Oncology Breakthroughs)
Madrid, Spain
SEE MORE
Scroll to Top